Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen

Prostate cancer represents a significant public health challenge, with its management requiring precise diagnostic and prognostic tools. Prostate-specific membrane antigen (PSMA), a cell surface enzyme overexpressed in prostate cancer cells, has emerged as a pivotal biomarker. PSMA’s ability to incr...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Omar Tayara, Sławomir Poletajew, Wojciech Malewski, Jolanta Kunikowska, Kacper Pełka, Piotr Kryst, Łukasz Nyk
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2024-07-01
Saila:	Current Oncology
Gaiak:	prostate-specific antigen (PSA) prostate-specific membrane antigen (PSMA) positron emission tomography (PET) computed tomography (CT) magnetic resonance imaging (MRI) Food and Drug Administration (FDA)
Sarrera elektronikoa:	https://www.mdpi.com/1718-7729/31/8/311
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!